CN110074299A - 一种枸杞益生菌发酵饮料及其制备方法 - Google Patents
一种枸杞益生菌发酵饮料及其制备方法 Download PDFInfo
- Publication number
- CN110074299A CN110074299A CN201910293049.3A CN201910293049A CN110074299A CN 110074299 A CN110074299 A CN 110074299A CN 201910293049 A CN201910293049 A CN 201910293049A CN 110074299 A CN110074299 A CN 110074299A
- Authority
- CN
- China
- Prior art keywords
- kilograms
- fructus lycii
- grams
- degree
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 20
- 230000004151 fermentation Effects 0.000 title claims abstract description 20
- 239000006041 probiotic Substances 0.000 title claims abstract description 11
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 11
- 235000013361 beverage Nutrition 0.000 title claims abstract description 10
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 13
- 235000009566 rice Nutrition 0.000 claims abstract description 13
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 7
- 241000186016 Bifidobacterium bifidum Species 0.000 claims abstract description 7
- 229930091371 Fructose Natural products 0.000 claims abstract description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 7
- 239000005715 Fructose Substances 0.000 claims abstract description 7
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 7
- 239000004376 Sucralose Substances 0.000 claims abstract description 7
- 229930006000 Sucrose Natural products 0.000 claims abstract description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 7
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims abstract description 7
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 7
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 7
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 7
- 235000019408 sucralose Nutrition 0.000 claims abstract description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 18
- 241000209094 Oryza Species 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 18
- 210000004185 liver Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 6
- 206010016654 Fibrosis Diseases 0.000 abstract description 5
- 230000007882 cirrhosis Effects 0.000 abstract description 5
- 208000019425 cirrhosis of liver Diseases 0.000 abstract description 5
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 5
- 230000004438 eyesight Effects 0.000 abstract description 5
- 230000009758 senescence Effects 0.000 abstract description 5
- 206010008909 Chronic Hepatitis Diseases 0.000 abstract description 4
- 206010021929 Infertility male Diseases 0.000 abstract description 4
- 208000007466 Male Infertility Diseases 0.000 abstract description 4
- 230000011132 hemopoiesis Effects 0.000 abstract description 4
- 208000006454 hepatitis Diseases 0.000 abstract description 4
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 208000004930 Fatty Liver Diseases 0.000 abstract description 3
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000006978 adaptation Effects 0.000 abstract description 3
- 208000026935 allergic disease Diseases 0.000 abstract description 3
- 230000007815 allergy Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 208000010706 fatty liver disease Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 239000006210 lotion Substances 0.000 abstract description 3
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 244000241838 Lycium barbarum Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000009285 allergic inflammation Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- 206010003495 Aspermia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010058359 Hypogonadism Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种枸杞益生菌发酵饮料，其特征在于：它是由下列重量成分组成：大米120‑180公斤，枸杞子30‑50公斤，白糖30‑70公斤，果糖40‑60公斤，三氯蔗糖50‑60克，山梨酸钾1‑2公斤，柠檬酸0.1‑1公斤，盐0.1‑0.5公斤，嗜热链球菌100‑300克，嗜酸乳杆菌150‑250克，两岐双岐杆菌150‑200克。本发明具有如下优点：口感上佳，提高机体免疫功能，增强机体适应调节能力，具有抗癌作用，具有显著的明目作用，提升精力，增强学习记忆，提高肌体适应性，增强人体造血功能，延缓衰老，美容养颜，降血脂降血压，治疗男性不育，强身壮阳，缓解过敏性炎症，保肝、防脂肪肝，降血糖，治疗糖尿病，治疗慢性肝炎、肝硬化。
Description
技术领域
本发明涉及食品技术领域，具体涉及一种枸杞益生菌发酵饮料及其制备方法。
背景技术
枸杞内含有丰富类胡萝种维生素以及钙、铁、锌、磷等多种微量元素，具有补肾益精，养肝明目，补血安神，生津止渴，润肺止咳等诸多功效，是广受人们喜爱的滋养补品，近些年来，枸杞相关产品日益增多，其中，枸杞饮料因具有充足的营养以及良好的口感而备受欢迎。目前市场上的枸杞饮料加工工艺通常包括清洗；破碎；果汁分离；糖酸调整以及杀菌包装等工序，口感稍微不佳。
发明内容
本发明所要解决的技术问题是提供一种功能多、营养丰富的枸杞益生菌发酵饮料。
为解决上述技术问题，本发明提供的技术方案为：一种枸杞益生菌发酵饮料，其特征在于：它是由下列重量成分组成：大米120-180公斤，枸杞子30-50公斤，白糖30-70公斤，果糖40-60公斤，三氯蔗糖 50-60克，山梨酸钾1-2公斤，柠檬酸0.1-1公斤，盐0.1-0.5公斤，嗜热链球菌100-300克，嗜酸乳杆菌 150-250克，两岐双岐杆菌150-200克。
一种权利要求1所述的一种枸杞益生菌发酵饮料的制备方法，其特征在于：步骤如下：
(1)、将枸杞洗净后在40度的温水中浸泡2小时，然后用胶体磨磨浆，后放入糖化罐加温至50度，加入果胶酶分解2小时，后放入分离机分离籽，通过板框过滤机过滤后进入发酵罐；
(2)、先用1000公斤水清洗大米，进入糖化罐将米煮透，后加入淀粉酶进行液化40分钟，降温至 60度时加入糖化酶糖化5小时，后进入分离机分离，再通过板框过滤机过滤后进入步骤(1)中的发酵罐；
(3)、按照步骤(1)和(2)中用量的1/10量生产料液，料液灭菌后加入嗜热链球菌、嗜酸乳杆菌、两岐双岐杆菌发酵14小时制备菌液；
(4)、枸杞糖化液和大米糖化液进入发酵罐，加温至98度，保温30分钟，然后降温至37度，加入步骤(3)中的菌液发酵；
(5)、发酵罐中的料液恒温37度，发酵38小时，当pH值达到3.8时停止发酵；
(6)、将发酵好的料液加入白糖、果糖、三氯蔗糖、山梨酸钾、柠檬酸和盐；
(7)、将步骤(6)中配好的料加温98度，保温30分钟，后降温至20度，通过网滤、均质机、UIT 杀菌、储罐、混合机、灌装、监测、旋盖、温罐、打印日期、装箱、称重、码垛、入库等步骤即得成品备售。
本发明具有如下优点：口感上佳，提高机体免疫功能，增强机体适应调节能力，具有抗癌作用，具有显著的明目作用，提升精力，增强学习记忆，提高肌体适应性，增强人体造血功能，延缓衰老，美容养颜，降血脂降血压，治疗男性不育，强身壮阳，缓解过敏性炎症，保肝、防脂肪肝，降血糖，治疗糖尿病，治疗慢性肝炎、肝硬化。
具体实施方式
枸杞具有如下功效：
1、提高机体免疫功能，增强机体适应调节能力。增强免疫功能的机理是通过调节中枢下丘脑与外周免疫器官脾脏交感神经释放去甲肾上腺素等单胺递质，及肾上腺皮质释放皮质激素等环节相互而实现的。在枸杞多糖调节下，机体在自身免疫力范围内可回升到正常幅度。
2、具有抗癌作用。枸杞子对癌细胞的生成和扩散有明显的抑制作用，当代实验和临床应用的结果表明，枸杞叶代茶常饮，能显著提高和改善老人、体弱多病者和肿瘤病人的免疫功能和生理功能，具有强壮肌体和延缓衰老的作用。对癌症患者配合化疗，有减轻毒副作用，防止白血球减少，调节免疫功能等疗效。试验研究发现:枸杞片中含有的微量元素锗有明显抑制癌细胞的作用，可使癌细胞完全破裂，抑制率达 100％。
3、具有显著的明目作用。枸杞子尤其擅长明目，所以还俗称“明眼子”。历代医家治疗肝血不足、肾阴亏虚引起的视物昏花和夜盲症，常常使用构杞子。著名方剂祀菊地黄丸,就以构杞子为主要药物。民间也习用枸杞子治疗慢性眼病，枸杞蒸蛋就是简便有效的食疗方。
4、具有提升精力的作用。枸杞子能显著增加肌糖原、肝糖原的贮备量，提高人体活力，有抗疲劳、持续补充精力的作用。
5、有增强学习记忆功能。枸杞子具有改善大脑的功能，增强人的学习记忆能力。
6、提高肌体的适应性。枸杞子能提高人体的适应性防御功能，使人遇到伤害性刺激时，如遇到缺氧、寒冷、失血等的忍耐承受能力。
7、可以增强人体的造血功能。枸杞子有明显促进造血细胞增殖的作用，可以使白细胞数增多，增强人体的造血功能。
8、可以有效地延缓衰老。枸杞子为扶正固本，生精补髓、港阴补肾、益气安神、强身健体、延缓衰老之良药，自古以来就是滋补强壮养人的上品，有效地增强各种脏腑功能，能改善大脑功能和对抗自由基的功能，具有明显的延缓衰老的作用。
9、具有美容肌肤的功能。很多人都不知道常吃枸杞子可以美容。这是因为，枸杞子可以提高皮肤吸收氧分的能力，另外，还能起到美白作用。枸杞子对银屑病有明显疗效，对其他些皮肤病也有不同程度的疗效。
10、具有强身壮阳、提高男性的性功能。作为滋补强壮剂治疗肾虚各症及肝肾疾病疗效甚佳，能显著提高人体中血浆睾酮素含量，达到强身壮阳之功效。对于性功能减退有明显的疗效。
11、治疗男性不有症。枸杞子对于少精症有提高精子数目和精子活力的作用，因此可以治疗男性不育症。
12、具有降血脂、治疗高血压。食用枸杞子可以显著降低血清胆固醇和三酰甘油的含量，减轻和防止动脉硬化，治疗高血压。是冠心病人的良好保健品。
13、对过敏性炎症有缓解作用。枸杞子对过敏引起的胃肠道、关节疼出等症状有缓解作用，这些作用是通过调节内分泌实现的。
14、具有保肝、抗脂肪肝的作用。枸杞子具有保肝补肾的作用，能抑制脂肪在肝细胞内沉积，并促进肝细胞的新生。
15、具有降血糖的作用，治疗糖尿病。由于枸杞子含有肌的行生物，可以降低血糖，因此枸杞子可以作为糖尿病人的保健品。
16、可以治疗肥胖症。每日用枸杞子冲茶，可以减轻体重，治疗肥胖症。
17、可以治疗慢性肝炎、肝硬化。枸杞子的有效成分枸櫞酸甜菜碱具有治疗慢性肝炎、肝硬化等肝脏疾病的作用，有很好的疗效。
实施例一
一种枸杞益生菌发酵饮料，其特征在于：它是由下列重量成分组成：大米150公斤，枸杞子40公斤，白糖50公斤，果糖50公斤，三氯蔗糖55克，山梨酸钾1.2公斤，柠檬酸0.2公斤，盐0.3公斤，嗜热链球菌200克，嗜酸乳杆菌200克，两岐双岐杆菌180克。
其制备步骤如下：
(1)、将40公斤枸杞洗净后在40度的温水中浸泡2小时，然后用胶体磨磨浆，后放入糖化罐加温至50度，加入果胶酶分解2小时，后放入分离机分离籽，通过板框过滤机过滤后进入发酵罐；
(2)、先用1000公斤水清洗大米150公斤，进入糖化罐将米煮透，后加入淀粉酶进行液化40分钟，降温至60度时加入糖化酶糖化5小时，后进入分离机分离，再通过板框过滤机过滤后进入步骤(1)中的发酵罐；
(3)、按照步骤(1)和(2)中用量的1/10量生产料液，料液灭菌后加入嗜热链球菌、嗜酸乳杆菌、两岐双岐杆菌发酵14小时制备菌液；
(4)、枸杞糖化液和大米糖化液进入发酵罐，加温至98度，保温30分钟，然后降温至37度，加入步骤(3)中的菌液发酵；
(5)、发酵罐中的料液恒温37度，发酵38小时，当pH值达到3.8时停止发酵；
(6)、将发酵好的料液加入白糖50公斤、果糖50公斤、三氯蔗糖55克、山梨酸钾1.2公斤、柠檬酸0.2公斤和盐0.3公斤；
(7)、将步骤(6)中配好的料加温98度，保温30分钟，后降温至20度，通过网滤、均质机、UIT 杀菌、储罐、混合机、灌装、监测、旋盖、温罐、打印日期、装箱、称重、码垛、入库等步骤即得成品备售。
由本发明制成的枸杞益生菌发酵饮料口感上佳，提高机体免疫功能，增强机体适应调节能力，具有抗癌作用，具有显著的明目作用，提升精力，增强学习记忆，提高肌体适应性，增强人体造血功能，延缓衰老，美容养颜，降血脂降血压，治疗男性不育，强身壮阳，缓解过敏性炎症，保肝、防脂肪肝，降血糖，治疗糖尿病，治疗慢性肝炎、肝硬化。
以上所述仅为本发明的优选实施例而已，并不用于限制本发明，对于本领域的技术人员来说，本发明可以有各种更改和变化。凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均包含在本发明的保护范围之内。
Claims (2)
1.一种枸杞益生菌发酵饮料，其特征在于：它是由下列重量成分组成：大米120-180公斤，枸杞子30-50公斤，白糖30-70公斤，果糖40-60公斤，三氯蔗糖50-60克，山梨酸钾1-2公斤，柠檬酸0.1-1公斤，盐0.1-0.5公斤，嗜热链球菌100-300克，嗜酸乳杆菌150-250克，两岐双岐杆菌150-200克。
2.一种权利要求1所述的一种枸杞益生菌发酵饮料的制备方法，其特征在于：步骤如下：
(1)、将枸杞洗净后在40度的温水中浸泡2小时，然后用胶体磨磨浆，后放入糖化罐加温至50度，加入果胶酶分解2小时，后放入分离机分离籽，通过板框过滤机过滤后进入发酵罐；
(2)、先用1000公斤水清洗大米，进入糖化罐将米煮透，后加入淀粉酶进行液化40分钟，降温至60度时加入糖化酶糖化5小时，后进入分离机分离，再通过板框过滤机过滤后进入步骤(1)中的发酵罐；
(3)、按照步骤(1)和(2)中用量的1/10量生产料液，料液灭菌后加入嗜热链球菌、嗜酸乳杆菌、两岐双岐杆菌发酵14小时制备菌液；
(4)、枸杞糖化液和大米糖化液进入发酵罐，加温至98度，保温30分钟，然后降温至37度，加入步骤(3)中的菌液发酵；
(5)、发酵罐中的料液恒温37度，发酵38小时，当pH值达到3.8时停止发酵；
(6)、将发酵好的料液加入白糖、果糖、三氯蔗糖、山梨酸钾、柠檬酸和盐；
(7)、将步骤(6)中配好的料加温98度，保温30分钟，后降温至20度，通过网滤、均质机、UIT杀菌、储罐、混合机、灌装、监测、旋盖、温罐、打印日期、装箱、称重、码垛、入库等步骤即得成品备售。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910293049.3A CN110074299A (zh) | 2019-04-12 | 2019-04-12 | 一种枸杞益生菌发酵饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910293049.3A CN110074299A (zh) | 2019-04-12 | 2019-04-12 | 一种枸杞益生菌发酵饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110074299A true CN110074299A (zh) | 2019-08-02 |
Family
ID=67414925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910293049.3A Pending CN110074299A (zh) | 2019-04-12 | 2019-04-12 | 一种枸杞益生菌发酵饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110074299A (zh) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103215169A (zh) * | 2013-04-22 | 2013-07-24 | 山东省食品发酵工业研究设计院 | 一种三菌固定化发酵冬枣格瓦斯及其制备方法 |
| CN103719994A (zh) * | 2013-12-30 | 2014-04-16 | 黑龙江省轻工科学研究院 | 一种糙米发酵饮料的制作方法 |
| CN104473272A (zh) * | 2014-12-02 | 2015-04-01 | 宁夏万齐米业有限公司 | 枸杞大米发酵乳及其制造方法 |
| CN104745391A (zh) * | 2015-04-07 | 2015-07-01 | 江苏洋河酒厂股份有限公司 | 一种低酒精度多粮格瓦斯及其生产方法 |
| CN105167072A (zh) * | 2015-08-02 | 2015-12-23 | 周学义 | 一种功能性枸杞酵素及其制品的生产方法 |
| CN107012042A (zh) * | 2017-03-20 | 2017-08-04 | 石河子大学 | 一种黑枸杞复合饮料及其制备方法 |
| CN107125525A (zh) * | 2017-07-06 | 2017-09-05 | 山西达明派食品有限公司 | 一种植物益生菌发酵枸杞浆的方法 |
| US20170347689A1 (en) * | 2015-01-14 | 2017-12-07 | Bingxin WU | A probiotic-fermented maca composition and a method for preparing the composition and use of the composition |
-
2019
- 2019-04-12 CN CN201910293049.3A patent/CN110074299A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103215169A (zh) * | 2013-04-22 | 2013-07-24 | 山东省食品发酵工业研究设计院 | 一种三菌固定化发酵冬枣格瓦斯及其制备方法 |
| CN103719994A (zh) * | 2013-12-30 | 2014-04-16 | 黑龙江省轻工科学研究院 | 一种糙米发酵饮料的制作方法 |
| CN104473272A (zh) * | 2014-12-02 | 2015-04-01 | 宁夏万齐米业有限公司 | 枸杞大米发酵乳及其制造方法 |
| US20170347689A1 (en) * | 2015-01-14 | 2017-12-07 | Bingxin WU | A probiotic-fermented maca composition and a method for preparing the composition and use of the composition |
| CN104745391A (zh) * | 2015-04-07 | 2015-07-01 | 江苏洋河酒厂股份有限公司 | 一种低酒精度多粮格瓦斯及其生产方法 |
| CN105167072A (zh) * | 2015-08-02 | 2015-12-23 | 周学义 | 一种功能性枸杞酵素及其制品的生产方法 |
| CN107012042A (zh) * | 2017-03-20 | 2017-08-04 | 石河子大学 | 一种黑枸杞复合饮料及其制备方法 |
| CN107125525A (zh) * | 2017-07-06 | 2017-09-05 | 山西达明派食品有限公司 | 一种植物益生菌发酵枸杞浆的方法 |
Non-Patent Citations (5)
| Title |
|---|
| LEO ZGGQW18704508319: "枸杞益生菌发酵饮料 好喝——益健康", 《搜狗微信，HTTPS://MP.WEIXIN.QQ.COM/S?SRC=3&TIMESTAMP=1634286367&VER=1&SIGNATURE=QB4IZY07O*WNNPN6BWMMWVONJ*FUSHDZ3P4D7KTAWL2APR9P-8IZPQ24FI0MWESFYIKZMOBSK0M*YDXUCEAAFZGCPKDJEIY6AZLRSIQN1CTQ6O7WUFZ9W61VEUJ2JSEEMBXX*13GE52FPH7VYC3XCFLQHUF5IEVJSC6RUMJP3SW=》 * |
| 昭子: "枸杞子16种神奇功效", 《现代养生》 * |
| 李超: "黑米玉米枸杞复合发酵饮料的研制", 《食品工业》 * |
| 王玲 等: "枸杞大米发酵饮料的研制", 《宁夏农学院学报》 * |
| 马栎等: "大米大豆枸杞复合饮料工艺研究", 《食品研究与开发》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101904504B (zh) | 五行酵素液的制备方法 | |
| CN105482953B (zh) | 一种富硒蓝莓保健酒的生产工艺 | |
| CN103609696A (zh) | 一种益智明目型酸奶及加工方法 | |
| CN102293430A (zh) | 一种具有抗氧化、增强免疫力的饮料及其制备方法 | |
| CN102965235B (zh) | 一种板栗养生酒 | |
| CN102965237A (zh) | 桑葚灵芝果酒及其生产方法 | |
| CN102160664A (zh) | 儿童营养饮料 | |
| CN102499291B (zh) | 一种具有美容养颜并提高机体免疫功能的奶粉及其制备方法 | |
| CN105495560A (zh) | 一种复合植物多糖与菌类多糖的营养食品 | |
| CN103238889B (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
| CN107252095A (zh) | 复合酵素及其制备方法 | |
| CN102524891A (zh) | 党参保健饮料及其制备方法 | |
| CN104544400A (zh) | 一种含冬虫夏草提取物的复配保健饮料的制备方法 | |
| CN110226688A (zh) | 一种桑葚黄精饮品及其制备方法 | |
| CN106635719A (zh) | 一种百香果醋及其制备方法 | |
| CN106281919A (zh) | 一种蛹虫草调制酒及其制备方法 | |
| CN104957624A (zh) | 一种人体植物配方保健品 | |
| CN104222287A (zh) | 一种能抗疲劳防衰老的保健牛奶及其制备方法 | |
| CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
| CN104450470B (zh) | 一种柘果保健酒及其制备方法 | |
| CN101112605A (zh) | 一种黑豆美容养颜暖醋 | |
| CN105325823A (zh) | 格瓦斯饮料及其制备方法 | |
| CN104886582A (zh) | 一种人体植物配方保健品 | |
| CN109043259A (zh) | 一种酵素l-阿拉伯糖水苏糖复合饮料浓浆 | |
| CN110074299A (zh) | 一种枸杞益生菌发酵饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |